{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T19:24:04Z","timestamp":1766690644035},"reference-count":10,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,4,29]],"date-time":"2007-04-29T00:00:00Z","timestamp":1177804800000},"content-version":"vor","delay-in-days":3680,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1997,4]]},"abstract":"<jats:p>The effectiveness and safety of fluticasone propionate aqueous nasal spray (200 \u03bcg once daily for 4 weeks) were compared with those of loratadine (10 mg once daily for 4 weeks) in 114 adults and adolescents with seasonal allergic rhinitis in this multicenter, double\u2010blind, double\u2010dummy, randomized, parallel\u2010group study. Patients recorded their nasal symptoms (nighttime and daytime obstruction, sneezing, itching, rhinorrhea, and overall discomfort) using a 4\u2010point scale (0=no symptoms, 3=very frequent symptoms) in daily diaries. Clinicians assessed patients' nasal symptoms (nighttime and daytime obstruction, sneezing, itching, and rhinorrhea) using a 4\u2010point scale at every scheduled visit. Clinicians and patients assessed the overall effectiveness of treatment at the end of the study. Fluticasone propionate improved clinician\u2010rated total nasal symptom scores (defined as the sum of five nasal symptoms) more than loratadine at the 2\u2010week and 4\u2010week assessments (<jats:italic>P<\/jats:italic>\u22650.008). Clinicians gave fluticasone propionate better global ratings than loratadine (<jats:italic>P<\/jats:italic>=0.04). After 4 weeks of treatment, between\u2010group differences in clinician\u2010rated individual nasal symptoms favored fluticasone propionate (<jats:italic>P<\/jats:italic>&lt;0.05), with the exception of nasal itching (<jats:italic>P<\/jats:italic>=0.11). These findings were confirmed by between\u2010group differences in the percentages of symptom\u2010free days calculated from patient\u2010recorded daily diary\u2010card data. Both treatments were well tolerated. The incidence of adverse events between groups was similar. Fluticasone propionate aqueous nasal spray 200 \u03bcg administered once daily in the morning was more effective than loratadine 10 mg administered once daily for the treatment of seasonal allergic rhinitis.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1997.tb01027.x","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:24:50Z","timestamp":1179102290000},"page":"445-450","source":"Crossref","is-referenced-by-count":18,"title":["Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis*"],"prefix":"10.1111","volume":"52","author":[{"given":"P.","family":"G\u00e9hanno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010L.","family":"Desfougeres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,29]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"5","article-title":"International Consensus Report on the Diagnosis and Management of Rhinitis","volume":"49","author":"International Rhinitis Management Working Group","year":"1994","journal-title":"Eur J Allergy Clin Immunol"},{"key":"e_1_2_1_3_2","first-page":"860","article-title":"Allergic rhinitis","volume":"325","author":"Naclerio RM","year":"1994","journal-title":"N Engl J Med"},{"key":"e_1_2_1_4_2","first-page":"13","article-title":"Treating allergic rhinitis. Overview and update","volume":"6","author":"Meltzer EO","year":"1992","journal-title":"Am J Asthma Allergy Pediatr"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0954-6111(08)80003-0","article-title":"Structure\u2010activity relationships of topically active steroids: the selection of fluticasone propionate","volume":"84","author":"Phillipps GH","year":"1990","journal-title":"Respir Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(08)80004-2"},{"key":"e_1_2_1_7_2","first-page":"86","article-title":"Intranasal fluticasone propionate is more effective than terfenadine for treatment of seasonal rhinitis [Abstract]","volume":"72","author":"Bronsky E","year":"1994","journal-title":"Ann Allergy"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420230086010"},{"key":"e_1_2_1_9_2","first-page":"196","article-title":"Intranasal fluticasone propionate vs loratadine in the treatment of adolescent patients with seasonal allergic rhinitis (SAR) [Abstract 221]","volume":"91","author":"Jordana G","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_10_2","first-page":"271","article-title":"Fluticasone propionate (FP) vs loratadine (1) in adolescents with seasonal allergic rhinitis (SAR): nasal obstruction and peak inspiratory flow (PIP) [Abstract 654]","volume":"93","author":"Jordana G","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)91918-J"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1997.tb01027.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1997.tb01027.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T04:21:10Z","timestamp":1698466870000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1997.tb01027.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,4]]}},"alternative-id":["10.1111\/j.1398-9995.1997.tb01027.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1997.tb01027.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,4]]}}}